SA
Straumann Holding AG
SAUHY · OTC
$11.42 +0.09% (+$0.01)
1M -4.10%
Market Cap CHF 15.1B
P/E Ratio 44.07x
Div. Yield 1.11%
ROE 16.03%
Bulios Fair Price
$9.39
17.8% downside
Current Price
$11.42
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SAUHY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
7 /100
Expensive EV/EBITDA 29.07x
P/S 6.06x
P/B 6.97x
Growth
34 /100
Stable Rev. growth 2.34%
FCF growth 12.54%
Book val. growth 5.32%
Profitability
86 /100
Strong Net margin 13.74%
Op. margin 21.07%
FCF margin 12.66%
Quality
71 /100
Excellent ROA 8.95%
Asset turnover 0.65x
ROE 16.03%
Debt
100 /100
Low Current ratio 2.21x
Net debt/EBITDA 0.33x
Debt/Equity 0.30x
Stability
66 /100
Moderate Rev. volatility 2.60%
EPS volatility 53.52%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SAUHY
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Guillaume Daniellot
Employees
11,824
Headquarters
Basel
Upcoming events
24 FEB
Earnings
Upcoming earnings report